Profile: AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

17.10USD
24 Apr 2015
Change (% chg)

$0.25 (+1.48%)
Prev Close
$16.85
Open
$16.83
Day's High
$17.26
Day's Low
$16.73
Volume
334,223
Avg. Vol
184,461
52-wk High
$19.80
52-wk Low
$13.06

Search Stocks

AngioDynamics, Inc., incorporated on July 27, 1992, is engaged in designing, manufacturing and selling a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company’s product offerings fall within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, Angiographic, as well as other products. Image-guided vascular access, or IGVA, involves the use of advanced imaging equipment to guide the placement of catheters that deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system. The Company’s Oncology/Surgery product offerings include Microwave Ablation products, Radiofrequency Ablation (RFA) and NanoKnife product lines.

Peripheral Vascular Products

The Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, Angiographic, as well as other products. The Company’s Fluid Management product offering includes the NAMIC Fluid Management portfolio. The Company manufactures convenience kits for customers, which incorporate the NAMIC devices they need for their procedures. NAMIC Squeeze Contrast Controller is designed to help labs minimize the amount of contrast wasted, the Squeeze Contrast Controller contrast management system contains two one-way check valves that prevent cross contamination of the contrast source, flexible chamber and green ball fluid level indicator. Perceptor Manifold and Compensator Manifold provide clinicians a manifold with an integral transducer and allows for single operator re-zeroing during the procedure, in the sterile field. Protection Station and Protection Station Plus provides clinicians an OSHA-compliant closed system that helps minimize exposure to blood borne pathogens and simplifies set up and clean up during a procedure.

Saver-7 and Acceler-8 Angiographic Control Syringes are NEW 7 milliliter and 8 milliliter Angiographic Control syringes that provide clinicians a small barrel designed to require less force during injection of contrast through a 4F Catheter and to provide smoother aspiration and injection. The Company’s venous products focus on the treatment of varicose veins and consist of VenaCure EVLT laser system and Sotradecol. The Company’s Thrombus Management product offerings include AngioVac Venous Drainage Cannula and thrombolytic products. The Company’s thrombolytic catheters include: Pulse Spray Infusion Catheters and Uni Fuse thrombolytic catheters and SpeedLyser. The Company manufactures angiographic catheters and guidewires that are available in more than 500 tip configurations and lengths. The Company’s angiographic catheters include Soft-Vu, AngiOptic, Accu-Vu, Mariner and AQUA Liner. The Company’s line of drainage products, The Total Abscession Family of Drainage Catheters, consists of Total Abscession General, Biliary, and Nephrostomy drainage catheters. The Company’s Micro Access sets provide interventional physicians a smaller introducer system for minimally-invasive procedures.

Vascular Access

Image-guided vascular access, or IGVA, involves the use of advanced imaging equipment to guide the placement of catheters that deliver primarily short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system. IGVA procedures include the placement of PICC lines, implantable ports and central venous catheters, or CVCs. The Company’s BioFlo products incorporate Endexo Technology into the manufacturing and design of Vascular Access products. Endexo is a fluorine based additive that creates a non-eluting (permanent), non-heparin based catheter material that is designed to reduce thrombus accumulation and platelet adhesion to all surfaces of the catheter. The Company’s peripherally inserted central catheter (PICC) products include: BioFlo PICC, BioFlo PICC with PASV Valve Technology, BioFlo PICC Hybrid with PASV Valve Technology, Xcela PICC with PASV Valve Technology, Xcela Power Injectible PICC, Xcela PICC Hybrid with PASV Valve Technology, Morpheus CT PICC and Morpheus CT PICC Insertion Kit and Morpheus Smart PICC. The Company’s port products and accessories include Vortex, SmartPort, Vaxcel Implantable Ports, Xcela Power Injectible Ports, Vaxcel and LifeGuard. The Company offers a variety of dialysis catheters, including: DuraMax, Schon, Evenmore, Vaxcel Plus, Dura-Flow 2 and SCHON XL.

Oncology / Surgery Products

The Company’s Oncology/Surgery product offerings include Microwave Ablation products, Radiofrequency Ablation (RFA) and NanoKnife product lines. The Acculis Microwave Tissue Ablation (MTA) System complements the full range of ablative technologies the Company offers. The Company’s Radiofrequency Ablation (RFA) products use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors. In addition to the intra-operative (open surgery) device Habib 4X, AngioDynamics markets a minimally-invasive version of the Habib 4X device, a Laparoscopic 4X unit, which is used in minimally invasive laparoscopic surgery (MILS) procedures in surgical specialties such as: Hepato-Biliary, GI, Surgical Oncology, Transplant Surgery and Urology (Partial Nephrectomy Resections). The Company’s NanoKnife Ablation System is for the surgical ablation of soft tissue. The NanoKnife Ablation System utilizes low energy direct current electrical pulses to permanently open pores in target cell membranes. These permanent pores or nano-scale defects in the cell membranes result in cell death. The treated tissue is then removed by the body’s natural processes in a matter of weeks, mimicking natural cell death.

The Company competes with Boston Scientific Corporation, Cook Medical, C.R. Bard, Medical Components, Inc., or Medcomp, Arrow International, Smiths Medical, Vascular Solutions, Covidien subsidiaries (Kendall, VNUS, EV3), Merit Medical, Terumo Medical Corporation, Total Vein Systems and Biolitec.

Company Address

AngioDynamics Inc

14 Plaza Dr
LATHAM   NY   12110-2166
P: +1518.7981215
F: +1302.6555049

Company Web Links

Search Stocks